Utility of glucagon in the emergency department

Larner, 1985, Insulin and oral hypoglycemic drugs: glucagon, 1490 Unger, 1971, Glucagon physiology and pathophysiology, New Engl J Med, 285, 443, 10.1056/NEJM197108192850806 Hall-Boyer, 1984, Glucagon: hormone or therapeutic agent?, Crit Care Med, 12, 584, 10.1097/00003246-198407000-00008 Chernow, 1988, Glucagon: a potentially important hormone in circulatory shock, Prog Clin Biol Res, 264, 285 Gotlin, 1970, Neonatal hypoglycemia, hyperinsulinism and absence of pancreatic alpha-cells, Lancet, 1, 1346, 10.1016/S0140-6736(70)91946-X Donowitz, 1975, Glucagon secretion in acute and chronic pancreatitis, Ann Intern Med, 83, 778, 10.7326/0003-4819-83-6-778 Howland, 1990, Glucagon, 378 Rappolt, 1989, NAGD regime (Naloxone [Narcan], activated charcoal, glucagon, doxapram [Dopram]) for the coma of drug related overdoses, Clin Toxicol, 16, 395, 10.3109/15563658008989967 Vukmir, 1991, Glucagon: prehospital therapy of hypoglycemia, Ann Emerg Med, 20, 375, 10.1016/S0196-0644(05)81658-0 Collier, 1987, Comparison of intravenous glucagon and dextrose in treatment of severe hypoglycemia in an accident and emergency department, Diabetes Care, 10, 712, 10.2337/diacare.10.6.712 Pontiroli, 1989, Intranasal glucagon as a remedy for hypoglycemia: studies in healthy patients and Type I diabetic patients, Diabetes Care, 12, 604, 10.2337/diacare.12.9.604 Slama, 1990, A new non-invasive method for treating insulin-reaction: Intranasal lyophilized glucagon, Diabetologia, 33, 6714, 10.1007/BF00400568 Chiou, 1988, Treatment of hypoglycemia with glucagon eye drops, J Ocular Pharm, 4, 179, 10.1089/jop.1988.4.179 Oldham, 1987, Treatment of the hospitalized hypolycemic patient, Diabetes Educ., 13, 310, 10.1177/014572178701300314 Marri, 1968, Glucagon in sulphonylurea hypoglycaemia?, Lancet, 1, 303, 10.1016/S0140-6736(68)90157-8 Davies, 1967, Need for glucagon in severe hypoglycaemia induced by sulphonylurea drugs, Lancet, 1, 363, 10.1016/S0140-6736(67)92898-X Taylor, 1978, Intramuscular or intravenous glucagon for sulphonylurea hypoglycaemia?, Eur J Clin Pharm, 14, 125, 10.1007/BF00607443 Becker, 1990, Sulfonylurea and related drugs Ellenhorn, 1988, Sulfonylureas, 440 Haddad, 1990, Miscellany, 1474 Mehta, 1987, Effect of diazoxide or glucagon on hepatic glucose production rate during extreme neonatal hypoglycaemia, Arch Dis Child, 62, 924, 10.1136/adc.62.9.924 Ziai, 1990, Disorders of metabolism, 82 Friedland, 1983, Tre treatment of acute esophageal food impaction, Radiology, 149, 601, 10.1148/radiology.149.2.6622713 Glauser, 1979, Intravenous glucagon in the management of esophageal food obstruction, JACEP, 8, 228, 10.1016/S0361-1124(79)80184-7 Giordano, 1981, Current management of esophageal foreign bodies, Arch Otolaryngol, 107, 249, 10.1001/archotol.1981.00790400051012 Trenkner, 1983, Esophageal food impaction: treatment with glucagon, Radiology, 149, 401, 10.1148/radiology.149.2.6622682 Smith, 1986, Use of glucagon and gas-forming agents in acute esophageal food impaction [letter], Radiology, 159, 567, 10.1148/radiology.159.2.567-c Kaszar-Seibert, 1990, Treatment of acute esophageal food impaction with a combination of glucagon, effervescent agent, and water, AJR, 154, 533, 10.2214/ajr.154.3.2106216 Lucchesi, 1968, Cardiac actions of glucagon, Circ Res, 22, 777, 10.1161/01.RES.22.6.777 Chernow, 1986, Glucagon: endocrine effects and calcium involvement in cardiovascular actions in dogs, Circ Shock, 19, 393 Levey, 1969, Activation of adenyl cyclase by glucagon in cat and human heart, Circ Res, 24, 151, 10.1161/01.RES.24.2.151 MacLeod, 1981, Characterization of glucagon-induced changes in rats, contractility and cyclic AMP levels in isolated cardiac preparations of the rat and guinea pig, J Pharmacol Exp Ther, 217, 798 Farah, 1983, Glucagon and the circulation, Pharmacol Rev., 35, 181 Chernow, 1987, Glucagon's chronotropic action is calcium dependent, J Pharmacol Exp Ther, 241, 833 LeClerq-Meyer, 1979, Calcium dependency of glucagon release: its modulation by nutritional factors, Am J Physiol, 5, E98 Malcolm, 1986, Glucagon is an antagonist of morphine bradycardia and antinociception, Life Sci, 39, 399, 10.1016/0024-3205(86)90519-9 Stewart, 1969, The effect of glucagon on quinidine-induced changes in Purkinje fibers, Circulation, 40, 196 Prasad, 1978, Glucagon in procainamide-induced cardiac toxicity, Toxicol Appl Pharmacol, 46, 517, 10.1016/0041-008X(78)90097-2 Farah, 1960, Studies on the pharmacology of glucagon, J Pharmacol Exp Ther, 129, 49 Sonnenblick, 1968, Oxygen consumption of the heart: Newer concepts of its multifactorial determination, Am J Cardiol, 22, 328, 10.1016/0002-9149(68)90117-3 Kones, 1971, Glucagon: present status in cardiovascular disease, Clin Pharmacol Ther, 12, 427, 10.1002/cpt1971123427 Smitherman, 1978, Cardiac dose response relationship for intravenously infused glucagon in normal intact dogs and men, Am Heart J, 96, 363, 10.1016/0002-8703(78)90048-0 Lydtin, 1982, Kreislaufwirkungen verschiedener Applikationsformen von Glucagon, Verh Dysch Ges Inn Med, 78, 1551 Newman, 1981, Epinephrine-resistant anaphylaxis in a patient taking propranolol hydrochloride, Ann Allergy, 47, 35 Perkin, 1985, Mechanisms and management of anaphylactic shock not responding to traditional therapy, Ann Allergy, 54, 202 Sheffer, 1985, Anaphylaxis, J Allergy Clin Immunol, 75, 227, 10.1016/0091-6749(85)90048-X Zaloga, 1986, Glucagon reversal of hypotension in a case of anaphylactoid shock [letter], Ann Intern Med, 105, 65, 10.7326/0003-4819-105-1-65 Kosinski, 1973, Glucagon and isoproterenol in reversing propranolol toxicity, Arch Intern Med, 132, 840, 10.1001/archinte.1973.03650120048009 Illingworth, 1979, Glucagon for beta-blocker poisoning, Practitioner, 223, 683 Frishman, 1979, Clinical pharmacology of the new beta-adrenergic blocking drugs; Part 8: Self-poisoning with beta-adrenoceptor blocking agents: recognition and management, Am Heart J, 98, 798, 10.1016/0002-8703(79)90480-0 Peterson, 1984, Glucagon therapy for beta-blocker overdose, DICP, 18, 394 Heath, 1984, Beta-adrenoreceptor blocker toxicity: clinical features and therapy, Am J Emerg Med, 2, 518, 10.1016/0735-6757(84)90078-0 Weinstein, 1984, Recognition and management of poisoning with beta-adrenergic blocking agents, Ann Emerg Med, 13, 1123, 10.1016/S0196-0644(84)80337-6 O'Mahony, 1990, Severe oxprenolol poisoning: the importance of glucagon infusion, Hum Exp Toxicol, 9, 101, 10.1177/096032719000900208 Zaritsky, 1988, Glucagon antagonism of calcium channel blocker-induced myocardial dysfunction, Crit Care Med, 16, 246, 10.1097/00003246-198803000-00008 Zaloga, 1985, Glucagon reverses the hypotension and bradycardia of verapamil overdose in rats, Crit Care Med, 13, 273, 10.1097/00003246-198504000-00036 Jolly, 1987, Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol, Pharmacology, 35, 249, 10.1159/000138317 Horowitz, 1989, Massive verapamil ingestion: a report of two cases and a review of the literature, Am J Emerg Med, 7, 624, 10.1016/0735-6757(89)90287-8 Quezado, 1991, Severe cardiac, respiratory, and metabolic complications of massive verapamil overdose, Crit Care Med, 19, 436, 10.1097/00003246-199103000-00028 Linden, 1985, Further uses of glucagon, Crit Care Med, 13, 248, 10.1097/00003246-198504000-00009 Erickson, 1991, Diltiazem overdose: case report and review, J Emerg Med, 9, 357, 10.1016/0736-4679(91)90380-X Parmley, 1968, Cardiovascular effects of glucagon in man, New Engl J Med, 279, 12, 10.1056/NEJM196807042790103 Nord, 1970, Treatment of congestive heart failure with glucagon, Ann Intern Med, 72, 649, 10.7326/0003-4819-72-5-649 Puri, 1979, Effects of glucagon on myocardial contractility and hemodynamics in acute experimental myocardial infarction: basis for its possible use in cardiogenic shock, Am Heart J, 78, 660, 10.1016/0002-8703(69)90518-3 Diamond, 1971, Acute myocardial infarction in man: comparative hemodynamic effects of norepinephrine and glucagon, Am J Cardiol, 27, 612, 10.1016/0002-9149(71)90224-4 Vander-Ark, 1979, Clinical evaluation of glucagon by continuous infusion in the treatment of low cardiac output states, Am Heart J, 79, 481, 10.1016/0002-8703(70)90253-X Lvoff, 1972, Glucagon in heart failure and in cardiogenic shock: experience in 50 patients, Circulation, 45, 534, 10.1161/01.CIR.45.3.534 Timmis, 1973, Prolonged glucagon infusion in cardiac failure, JAMA, 223, 293, 10.1001/jama.1973.03220030031007 Scheuer, 1979, The effect of pharmacological agents upon the dynamics of anoxic perfused rat hearts, 137, 1355 Busuttil, 1974, Protective effect of glucagon on the isolated perfused rat heart following severe hypoxia, 147, 527 Gruhzit, 1953, Determination of the therapeutic range of gitalin in the heart-lung preparation of the dog, J Pharmacol Exp Ther, 108, 112 Modlin, 1980, Clinical usefulness of glucagon, Surgery, 87, 470 Mancini, 1985, Inotropic drugs for the treatment of heart failure, J Clin Pharmacol, 25, 549, 10.1177/009127008502500710 Bourdarias, 1983, Inotropic agents in the treatment of cardiogenic shock, Pharmac Ther, 22, 53, 10.1016/0163-7258(83)90052-9 Colucci, 1986, New positive inotropic agents in the treatment of congestive heart failure: mechanisms of action and recent clinical developments, New Engl J Med, 314, 290, 10.1056/NEJM198601303140506 Higgins, 1987, Pharmacotherapy of circulatory shock, Disease-A-Month, 33, 311, 10.1016/0011-5029(87)90017-4 Bower, 1970, Hemodynamic effects of glucagon following hemorrhagic and endotoxic shock in the dog, Arch Surg, 101, 411, 10.1001/archsurg.1970.01340270059016 Vanderwall, 1970, Effect of glucagon in hemorrhagic shock, J Surg Oncology, 2, 177, 10.1002/jso.2930020213 Bowman, 1972, Renal effects of glucagon in rhesus monkeys during hypovolemia, Surg Gynecol Obstet, 134, 937 Madden, 1971, Failure of glucagon in experimental hemorrhagic shock, Am J Surg, 122, 502, 10.1016/0002-9610(71)90475-2 Weingand, 1986, Metabolic effects of glucagon in endotoxemic minipigs, Circ Shock, 18, 289 Boyd, 1989, The pharmacotherapy of septic shock, Crit Care Clin, 5, 133, 10.1016/S0749-0704(18)30454-8 Niemann, 1987, Postcountershock pulseless rhythms: hemodynamic effects of glucagon in a canine model, Crit Care Med, 15, 554, 10.1097/00003246-198706000-00003 Ferrucci, 1976, Hypotonic cholangiography with glucagon, Radiology, 118, 466, 10.1148/118.2.466 Jones, 1980, Narcotic-induced choledochoduodenal sphincter spasm reversed by glucagon, Anesth Analg, 59, 946, 10.1213/00000539-198012000-00011 Jones, 1981, Incidence of choledochoduodenal sphincter spasm during fentanyl-supplemented anesthesia, Anesth Analg, 60, 638, 10.1213/00000539-198109000-00005 Stower, 1982, A trial of glucagon in the treatment of painful biliary tract disease, Br J Surg, 69, 591, 10.1002/bjs.1800691011 Wilson, 1990, Glucagon as a therapeutic agent in the treatment of asthma, J Emerg Med, 8, 127, 10.1016/0736-4679(90)90220-P Sherman, 1988, A bronchodilator action of glucagon, J Allergy Clin Immunol, 81, 908, 10.1016/0091-6749(88)90949-9 Imbruce, 1975, The effect of glucagon on airway resistance, J Clin Pharmacol, 15, 680, 10.1002/j.1552-4604.1975.tb05920.x Daniel, 1974, Use of glucagon in the treatment of acute diverticulitis, Brit Med J, 3, 720, 10.1136/bmj.3.5933.720 Almy, 1980, Diverticular disease of the colon, New Engl J Med, 302, 324, 10.1056/NEJM198002073020605 Pinckney, 1980, Excretory urography with glucagon, Radiology, 135, 513, 10.1148/radiology.135.2.7367649 Hillman, 1980, Improved pyeloureteral visualization using glucagon during experimental intravenous urography, Invest Radiol, 15, 313, 10.1097/00004424-198007000-00007 Nepper-Rasmussen, 1984, Glucagon and ureteric colic, Urol Res, 12, 23, 10.1007/BF00256305 Zobbe, 1986, Glucagon in acute ureteral colic, Eur Urol., 12, 28, 10.1159/000472572 Webb, 1986, Glucagon and ureteric colic, Med J Austral, 144, 124, 10.5694/j.1326-5377.1986.tb112236.x Minkov, 1988, A new method for the management of ureteral colic after extracorporeal shock wave lithotripsy, Int Urol Nephrol, 20, 251, 10.1007/BF02549511 Kahnoski, 1987, Efficacy of glucagon in the relief of ureteral colic following treatment by extracorporeal shock wave lithotripsy: a randomized double-blind trial, J Urol, 137, 1124, 10.1016/S0022-5347(17)44425-9 Steinberg, 1987, Treatment of acute pancreatitis: comparison of animal and human studies, Gastroenterology, 93, 1420, 10.1016/0016-5085(87)90275-7 Gilsanz, 1978, Glucagon vs anticholinergics in the treatment of acute pancreatitis: a double-blind controlled trial, Arch Intern Med, 138, 535, 10.1001/archinte.1978.03630280017011 Hoy, 1977, The use of glucagon in the diagnosis and management of ileocolic intussusception, J Ped Surg, 12, 939, 10.1016/0022-3468(77)90604-2 Walker, 1984, Intussusception: a case review, South Med J, 77, 336, 10.1097/00007611-198403000-00017 Franken, 1983, The use of glucagon in hydrostatic reduction of intussusception: a double-blind study of 30 patients, Radiology, 146, 687, 10.1148/radiology.146.3.6828682 Bowen, 1985, Intussusception and glucagon, South Med J, 78, 895, 10.1097/00007611-198507000-00040 Kazmers, 1984, Pharmacologic interventions in acute mesenteric ischemia: improved survival with intravenous glucagon, methylprednisolone, and prostacyclin, J Vasc Surg, 1, 472, 10.1016/0741-5214(84)90088-0 Boorstein, 1988, Pharmacologic treatment of occlusive mesenteric ischemia in rats, J Surg Res, 44, 555, 10.1016/0022-4804(88)90161-8 Clark, 1990, Glucagon potentiates intestinal reperfusion injury, J Vasc Surg, 11, 270, 10.1016/0741-5214(90)90270-K Kreel, 1975, Pharmaco-radiology in barium examinations with special reference to glucagon, Br J Radiol, 48, 691, 10.1259/0007-1285-48-573-691 Harried, 1976, Glucagon and barium enema examinations: a controlled clinical trial, AJR, 126, 981, 10.2214/ajr.126.5.981 Miller, 1973, Hypotonic duodenography with glucagon, Radiology, 108, 35, 10.1148/108.1.35 Ratcliffe, 1980, Glucagon in barium examinations in infants and children: special reference to dosage, Br J Radiol, 53, 860, 10.1259/0007-1285-53-633-860 Berger, 1979, Computed tomography and ultrasound in the diagnosis of neuroblastoma, Radiology, 128, 663, 10.1148/128.3.663 Gerner, 1983, Premedication in upper gastrointestinal endoscopy: a comparison of glucagon and atropine given in combination with diazepam and pethidine, Scand J Gastroenterol, 18, 925, 10.3109/00365528309182116 Hughes, 1990, Endoscopy gastric polypectomy, 194 Ziegels, 1979, Opacification par voie rétrograde des canaux biliares et pancréatiques, Rev Méd Liège, 34, 928 Norfleet, 1978, Premedication for colonoscopy: randomized, double blind study of glucagon versus placebo, Gastrointest Endosc, 24, 64, 10.1016/S0016-5107(78)73496-6 Foster, 1981, Outpatient flexible fibreoptic sigmoidoscopy, diagnostic yield and the value of glucagon, Br J Surg, 68, 463, 10.1002/bjs.1800680707 Juan, 1981, Pheochromocytoma: clinical manifestations and diagnostic tests, Urology, 17, 1, 10.1016/0090-4295(81)90002-9 Sheps, 1968, Histamine and glucagon tests in diagnosis of pheochromocytoma, JAMA, 205, 895, 10.1001/jama.1968.03140390019004 Beggs, 1978, Phaeochromocytoma diagnosed during barium meal, Br J Radiol, 51, 918, 10.1259/0007-1285-51-611-918 Schoor, 1987, Intraoperative cardiovascular crisis caused by glucagon, Arch Surg, 122, 833, 10.1001/archsurg.1987.01400190099022 Lebovics, 1991, Glucagon precipitation of carcinoid flush, Gastrointest Endosc, 37, 212, 10.1016/S0016-5107(91)70700-1 Chernish, 1990, Glucagon: common untoward reactions—review and recommendations, Radiology, 177, 145, 10.1148/radiology.177.1.2204958 Chernish, 1988, The laboratory response to glucagon dosages used in gastrointestinal examinations, Invest Radiol, 23, 847, 10.1097/00004424-198811000-00009 Edell, 1980, Erythema multiforme secondary to intravenous glucagon, AJR, 134, 385, 10.2214/ajr.134.2.385 1990 Xavras, 1990, Glucagon-induced severe anaphylactic reaction, ROFO, 152, 110, 10.1055/s-2008-1046831